These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer. Yadav MP; Ballal S; Tripathi M; Damle NA; Sahoo RK; Seth A; Bal C Nucl Med Commun; 2017 Jan; 38(1):91-98. PubMed ID: 27782913 [TBL] [Abstract][Full Text] [Related]
17. Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions. Wang J; Zang J; Wang H; Liu Q; Li F; Lin Y; Huo L; Jacobson O; Niu G; Fan X; Zhu Z; Chen X Clin Nucl Med; 2019 Jun; 44(6):431-438. PubMed ID: 30985422 [TBL] [Abstract][Full Text] [Related]
18. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT. Gosewisch A; Ilhan H; Tattenberg S; Mairani A; Parodi K; Brosch J; Kaiser L; Gildehaus FJ; Todica A; Ziegler S; Bartenstein P; Böning G EJNMMI Res; 2019 Aug; 9(1):76. PubMed ID: 31414241 [TBL] [Abstract][Full Text] [Related]
19. Streamlined Schemes for Dosimetry of Kurth J; Heuschkel M; Tonn A; Schildt A; Hakenberg OW; Krause BJ; Schwarzenböck SM Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359784 [TBL] [Abstract][Full Text] [Related]
20. Is a single late SPECT/CT based kidney Beykan S; Tran-Gia J; Borup Jensen S; Lassmann M Phys Med; 2022 Aug; 100():39-50. PubMed ID: 35724608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]